scholarly article | Q13442814 |
P2093 | author name string | Pollack IF | |
Ashkenazi A | |||
Erff M | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | apoptotic process | Q14599311 |
P304 | page(s) | 1362-1369 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. | |
P478 | volume | 7 |
Q40605148 | Adenoviral (full-length) Apo2L/TRAIL gene transfer is an ineffective treatment strategy for malignant glioma |
Q34384021 | Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer |
Q37412514 | Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey |
Q31087174 | Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector |
Q43273738 | Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis |
Q35665706 | Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. |
Q21136372 | Dynamic computational model suggests that cellular citizenship is fundamental for selective tumor apoptosis |
Q37262805 | EGFR-targeted diphtheria toxin stimulates TRAIL killing of glioblastoma cells by depleting anti-apoptotic proteins |
Q43013506 | Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells |
Q37021699 | Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistance |
Q35670756 | Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis |
Q34060387 | Histone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway |
Q34219368 | Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibody |
Q38943252 | Identification of death receptors DR4 and DR5 in HTB-12 astrocytoma cell lines and determination of TRAIL sensitivity |
Q37022290 | Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo |
Q40396320 | Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma |
Q38115574 | Manipulating the apoptotic pathway: potential therapeutics for cancer patients |
Q35110762 | Molecular pathology of tumor metastasis III. Target array and combinatorial therapies |
Q39137284 | Neural stem cell-based gene therapy for brain tumors |
Q37586895 | Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer |
Q39129326 | Oncolytic viruses: emerging options for the treatment of breast cancer |
Q37761935 | Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics |
Q40158789 | Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling |
Q37440765 | TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies |
Q34291312 | TRAIL in cancer therapy: present and future challenges |
Q37016549 | TRAIL induces apoptosis in oral squamous carcinoma cells--a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5. |
Q36614139 | TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells |
Q37972139 | TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment. |
Q35172090 | The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases |
Q36312145 | The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma |
Q38981224 | The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells |
Q41313717 | Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer Cells |
Search more.